DDL Biopharma AS

 

DDL Biopharma AS was established in April 2010 as a wholly owned subsidiary of Drug Discovery Laboratory AS.

The company is headed by Aase Jorun Klaveness, M. Sc. Pharm.

The most promising project within treatment of skin conditions will be taken into preclinical and clinical development in DDL Biopharma AS.  The new chemical compound, resulting from research activities in Drug Discovery Laboratory AS, is a potent version of another anti-acne compound in current clinical use.  Product patents have been issued in Europe, US, Japan and China.

Possible investors will in due course be welcome to join this project.